HUE040487T2 - Csatornarodopszin-2 (CHOP2) mutációk azonosítása és alkalmazási eljárások - Google Patents

Csatornarodopszin-2 (CHOP2) mutációk azonosítása és alkalmazási eljárások

Info

Publication number
HUE040487T2
HUE040487T2 HUE13710253A HUE13710253A HUE040487T2 HU E040487 T2 HUE040487 T2 HU E040487T2 HU E13710253 A HUE13710253 A HU E13710253A HU E13710253 A HUE13710253 A HU E13710253A HU E040487 T2 HUE040487 T2 HU E040487T2
Authority
HU
Hungary
Prior art keywords
arodopsin
chop2
mutations
identification
channel
Prior art date
Application number
HUE13710253A
Other languages
English (en)
Hungarian (hu)
Inventor
Zhuo-Hua Pan
Original Assignee
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wayne State filed Critical Univ Wayne State
Publication of HUE040487T2 publication Critical patent/HUE040487T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/405Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from algae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HUE13710253A 2012-03-05 2013-03-05 Csatornarodopszin-2 (CHOP2) mutációk azonosítása és alkalmazási eljárások HUE040487T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261606663P 2012-03-05 2012-03-05

Publications (1)

Publication Number Publication Date
HUE040487T2 true HUE040487T2 (hu) 2019-03-28

Family

ID=47892055

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13710253A HUE040487T2 (hu) 2012-03-05 2013-03-05 Csatornarodopszin-2 (CHOP2) mutációk azonosítása és alkalmazási eljárások

Country Status (16)

Country Link
US (3) US10947281B2 (enExample)
EP (1) EP2822964B1 (enExample)
JP (3) JP6395611B2 (enExample)
KR (1) KR102137717B1 (enExample)
CN (2) CN111378020A (enExample)
AU (4) AU2013230112A1 (enExample)
CA (1) CA2866405A1 (enExample)
DK (1) DK2822964T3 (enExample)
EA (1) EA201491643A1 (enExample)
ES (1) ES2703324T3 (enExample)
HU (1) HUE040487T2 (enExample)
MX (1) MX360085B (enExample)
NZ (1) NZ629843A (enExample)
PL (1) PL2822964T3 (enExample)
PT (1) PT2822964T (enExample)
WO (1) WO2013134295A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8470790B2 (en) 2006-05-04 2013-06-25 Wayne State University Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids
US9453241B2 (en) 2010-05-04 2016-09-27 Wayne State University AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells
CN111378020A (zh) 2012-03-05 2020-07-07 韦恩州立大学 通道视蛋白-2(Chop2)突变的鉴定及使用方法
WO2014160281A2 (en) 2013-03-14 2014-10-02 Wayne State University Method of enhancing delivery of therapeutic compounds to the eye
US10234761B2 (en) 2013-07-08 2019-03-19 Basf Se Oxime ester photoinitiators
WO2015138616A1 (en) 2014-03-11 2015-09-17 Wayne State University A modified mglur6 promoter and methods of use
KR20230160967A (ko) 2016-05-03 2023-11-24 웨인 스테이트 유니버시티 프로테오좀 억제제를 사용하여 눈에서 바이러스 매개 유전자 전달을 향상시키는 방법
JP2019522469A (ja) * 2016-06-03 2019-08-15 マックス−プランク−ゲゼルシャフト ツア フェルデルンク デア ヴィッセンシャフテン エー.ファウ. チャネルロドプシンの変異型光誘導性イオンチャネル
RU2019109021A (ru) * 2016-08-29 2020-09-29 Уэйн Стейт Юниверсити Идентификация мутаций в вариантах каналопсина, имеющих улучшенную чувствительность к свету, и способы их применения
WO2018106369A2 (en) * 2016-11-06 2018-06-14 Nanoscope Technologies Llc Optogenetic modulation by multi-characteristic opsins for vision restoration and other applications thereof
WO2018189247A1 (en) * 2017-04-12 2018-10-18 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. New optogenetic tool
SG11202004940VA (en) * 2017-12-04 2020-06-29 Salvat Lab Sa Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye
JP6567153B1 (ja) * 2018-09-28 2019-08-28 学校法人東北工業大学 対象化合物の特性の予測を行うための方法、コンピュータシステム、プログラム
WO2024226667A2 (en) * 2023-04-24 2024-10-31 Nanoscope Therapeutics Inc. Optogenetic modulation by multi-characteristic opsins for vision restoration and other applications thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4498919A (en) 1983-10-31 1985-02-12 Corning Glass Works Method for making colored photochromic prescription ophthalmic lenses
US6610287B1 (en) 1990-04-16 2003-08-26 The General Hospital Corporation Transfer and expression of gene sequences into nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
US5827702A (en) 1994-10-31 1998-10-27 Genentech, Inc. Ocular gene therapy
EP0977880A2 (en) 1997-04-21 2000-02-09 University Of Florida Materials and methods for treatment of retinal diseases
WO2000015822A1 (en) 1998-09-17 2000-03-23 University Of Florida Methods for treatment of degenerative retinal diseases
CA2406743A1 (en) 2000-04-28 2001-11-08 The Trustees Of The University Of Pennsylvania Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
EP1381276A4 (en) 2001-04-13 2005-02-02 Univ Pennsylvania METHOD FOR TREATMENT OR DEVELOPMENT SLUDGE DEGRADATION
WO2003016486A2 (en) 2001-08-16 2003-02-27 Sloan Kettering Institute For Cancer Research Bio-synthetic photostimulators and methods of use
DE10216005A1 (de) 2002-04-11 2003-10-30 Max Planck Gesellschaft Verwendung von biologischen Photorezeptoren als direkt lichtgesteuerte Ionenkanäle
WO2004009022A2 (en) 2002-07-18 2004-01-29 The General Hospital Corp. Method for augmenting vision in persons suffering from photoreceptor cell degeneration
US7186699B2 (en) 2003-06-03 2007-03-06 Cell Genesys, Inc. Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
JP2007527738A (ja) 2003-11-05 2007-10-04 ニューロヴィジョン, インコーポレイテッド 視覚を改善するための方法および装置
US20070053996A1 (en) 2005-07-22 2007-03-08 Boyden Edward S Light-activated cation channel and uses thereof
US8470790B2 (en) * 2006-05-04 2013-06-25 Wayne State University Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids
US9453241B2 (en) 2010-05-04 2016-09-27 Wayne State University AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells
SI2614079T1 (sl) * 2010-09-08 2015-10-30 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. Mutantski kanalnirodopsin 2
CN111378020A (zh) * 2012-03-05 2020-07-07 韦恩州立大学 通道视蛋白-2(Chop2)突变的鉴定及使用方法
KR101639859B1 (ko) * 2014-03-06 2016-07-14 포항공과대학교 산학협력단 광 자극에 의한 미토콘드리아 활성의 시공간적 가역 조절 방법

Also Published As

Publication number Publication date
HK1205744A1 (en) 2015-12-24
EA201491643A1 (ru) 2015-02-27
PL2822964T3 (pl) 2019-05-31
CA2866405A1 (en) 2013-09-12
AU2021245195B2 (en) 2023-09-28
KR102137717B1 (ko) 2020-07-27
JP2019193656A (ja) 2019-11-07
AU2017239601B2 (en) 2019-05-16
NZ727041A (en) 2022-01-28
MX2014010664A (es) 2015-03-06
AU2017239601A1 (en) 2017-10-26
EP2822964B1 (en) 2018-08-22
CN104334575A (zh) 2015-02-04
NZ629843A (en) 2017-03-31
AU2013230112A1 (en) 2014-09-25
CN111378020A (zh) 2020-07-07
US20150044181A1 (en) 2015-02-12
AU2021245195A1 (en) 2021-11-04
WO2013134295A1 (en) 2013-09-12
US10947281B2 (en) 2021-03-16
DK2822964T3 (en) 2018-12-10
EP2822964A1 (en) 2015-01-14
ES2703324T3 (es) 2019-03-08
US20220033449A1 (en) 2022-02-03
JP2015510759A (ja) 2015-04-13
KR20140132401A (ko) 2014-11-17
MX360085B (es) 2018-10-10
JP6395611B2 (ja) 2018-09-26
JP2018134098A (ja) 2018-08-30
PT2822964T (pt) 2018-11-29
AU2019216638B2 (en) 2021-07-08
US20250066431A1 (en) 2025-02-27
AU2019216638A1 (en) 2019-09-05

Similar Documents

Publication Publication Date Title
HUE040487T2 (hu) Csatornarodopszin-2 (CHOP2) mutációk azonosítása és alkalmazási eljárások
HUE040111T2 (hu) Vegyületek és alkalmazási eljárásaik
IL275998B (en) Medical system
HUE054881T2 (hu) Nyomtatási rendszer és eljárás
HUE037021T2 (hu) DLL3- modulátorok és eljárások alkalmazásukra
DK2925782T3 (da) Anti-cd47-antistoffer og fremgangsmåder til anvendelse deraf
HUE044123T2 (hu) Csepegtetõ készülék és eljárás
EP2930714A4 (en) Singing voice synthesizing system and singing voice synthesizing method
HUE043260T2 (hu) Képfeldolgozó eszköz és képfeldolgozási eljárás
EP2698985A4 (en) Imaging system and imaging method
DK2909427T3 (da) Tætningsanordning og -fremgangsmåde
HUE053410T2 (hu) Alkalmazási eljárás és alkalmazási berendezés
BR112014021287A2 (pt) Grampo cirúrgico
IL236002A0 (en) Aggregation of data bearers for carrier aggregation
HUE071157T2 (hu) Képdekódoló eljárás és képdekódoló berendezés
DK2917763T3 (da) Lidar-målesystem og lidar-målefremgangsmåde
DK2854883T3 (da) Biomatrix-hydrogeler og fremgangsmåder til anvendelse deraf
EP2893490A4 (en) SYSTEM AND METHOD FOR FAST RECOVERY OF MEDICAL INFORMATION
HUE054444T2 (hu) Prolinnal lezárt kapcsos peptidek és felhasználásuk
EP2818363A4 (en) CAMERA DEVICE, CAMERA SYSTEM, AND CAMERA CALIBRATION METHOD
DK2895101T3 (da) Forbedret kirurgisk template
HUE040066T2 (hu) Eljárások és felszerelések tumorok molekuláris szubtipizálásához
HUE040336T2 (hu) Biológiai hatóanyagot és fluopikolidot tartalmazó készítmény
BR112014020761A2 (pt) Aparelho médico e método
DK3003117T3 (da) Videolaryngoskop og laryngoskopindføringsdel